PCV82 Simulation of Long-Term Clinical Benefits and Costs of Add-On Therapy with Aliskiren in Hypertensive Patients with Diabetic Nephropathy: A German Statutory Health Insurance Perspective
2011
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI